跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tyrosine S
首页
药物
Tyrosine S
Tyrosine S
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Tricyclic Compounds Having Cytostatic and/or Cytotoxic Activity and Methods of Use Thereof
EP 2807927 A1
申请人: UNIV HOLY GHOST DUQUESNE
优先权: 2007
EP
US
12 件公开
PROCESS FOR PREPARING BTK INHIBITORS
EP 4545537 A3
申请人: HOFFMANN LA ROCHE
优先权: 2021
EP
US
WO
7 件公开
EP 3825317 A3
申请人: HOFFMANN LA ROCHE
优先权: 2016
EP
US
5 件公开
DOSAGE FORM COMPOSITIONS COMPRISING AN INHIBITOR OF BRUTON S TYROSINE KINASE
EP 4529956 A3
申请人: HOFFMANN LA ROCHE
优先权: 2016
CN
EP
US
5 件公开
Quinazoline derivatives having tyrosine kinase inhibitory activity
US 8202879 B2
申请人: KUME MASAHARU
优先权: 2005
CN
US
5 件公开
IMMUNOGENIC COMPOUNDS
EP 4192493 A1
申请人: AC IMMUNE SA
优先权: 2020
CN
EP
US
WO
4 件公开
COMPOSITION FOR PREVENTING OR TREATING DENTAL CARIES
US 20250195603 A1
申请人: HYSENSBIO CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
PEPTIDE PROMOTING TYROSINASE ACTIVITY AND USE THEREOF
US 20260070944 A1
申请人: HYSENSBIO CO LTD
优先权: 2022
CN
EP
US
WO
4 件公开
Crystalline salt of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof
US 11787819 B2
申请人: MIRATI THERAPEUTICS INC
优先权: 2021
CN
US
WO
4 件公开
METHODS OF TREATING B-CELL MALIGNANCY USING BCL-2 INHIBITOR
EP 4351542 A4
申请人: BEIGENE SWITZERLAND GMBH
优先权: 2021
EP
US
WO
4 件公开
Polypeptide for preventing or treating idiopathic pulmonary fibrosis and pharmaceutical composition containing the same
US 12679867 B2
申请人: NEXEL CO LTD
优先权: 2021
CN
EP
US
4 件公开
第 1 / 10 页
上一页
下一页
药物
反馈